Inhaled Zanamivir vs Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Study

Su, Chia PingChia PingSuChan, K ArnoldK ArnoldChanHuang, Ching TaiChing TaiHuangCHI-TAI FANG2023-01-172023-01-172022-10-121058-4838https://scholars.lib.ntu.edu.tw/handle/123456789/627368Meta-analyses of individual patient data from randomized, controlled trials show that early oseltamivir treatment for influenza cut the risk of pneumonia and hospitalization by 44% and 63%, respectively. However, data on the effectiveness of inhaled zanamivir in preventing hospitalization and death are lacking.encomplications; effectiveness; influenza; oseltamivir; zanamivirInhaled Zanamivir vs Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Studyjournal article10.1093/cid/ciac217352992452-s2.0-85139804059WOS:000790912200001https://api.elsevier.com/content/abstract/scopus_id/85139804059